Cargando…
No evidence for involvement of SDHD in neuroblastoma pathogenesis
BACKGROUND: Deletions in the long arm of chromosome 11 are observed in a subgroup of advanced stage neuroblastomas with poor outcome. The deleted region harbours the tumour suppressor gene SDHD that is frequently mutated in paraganglioma and pheochromocytoma, which are, like neuroblastoma, tumours o...
Autores principales: | De Preter, Katleen, Vandesompele, Jo, Hoebeeck, Jasmien, Vandenbroecke, Caroline, Smet, Jöel, Nuyts, Annick, Laureys, Geneviève, Combaret, Valérie, Van Roy, Nadine, Roels, Frank, Van Coster, Rudy, Praet, Marleen, De Paepe, Anne, Speleman, Frank |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC517501/ https://www.ncbi.nlm.nih.gov/pubmed/15331017 http://dx.doi.org/10.1186/1471-2407-4-55 |
Ejemplares similares
-
CADM1 is a strong neuroblastoma candidate gene that maps within a 3.72 Mb critical region of loss on 11q23
por: Michels, Evi, et al.
Publicado: (2008) -
The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy
por: Van Roy, Nadine, et al.
Publicado: (2009) -
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
por: Decock, Anneleen, et al.
Publicado: (2012) -
Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes
por: De Preter, Katleen, et al.
Publicado: (2006) -
Correction: Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes
por: De Preter, Katleen, et al.
Publicado: (2007)